ClinicalTrials HQ

Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer

Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer

Recruiting · NCT06896890 · Registry updated 2025-03-26
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung CancerNeoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Respiratory Aspiration, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 1 / Phase 22025-03-26NCT06896890

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Inhatarget Therapeutics1

15 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AZ DeltaRoeselareBelgium25
AZ GroeningeKortrijkBelgium18
Centre François Baclesse de CaenCaenFrance1
CHU Ambroise ParéMonsBelgium3
CHU Helora - Site JolimontJolimontBelgium1
CHU Sart TilmanLiègeBelgium3
GHDCCharleroiBelgium2
Hospital Universitario 12 De OctubreMadridSpain98
Hospital Universitario La PAZ, IdiPAZMadridSpain1
Hospital Universitario Virgen del RocíoSevilleSpain37
Hôpital Européen Georges Pompidou, Paris-Cite UniversityParisFrance1
Institut Jules Bordet - Hôpital Universitaire de BruxellesBrusselsBelgium1
Instituto Oncologico Dr Rosell, Hospital Universitario DexeusBarcelonaSpain1
L'Institut de Cancérologie de l'OuestSaint-HerblainFrance1
Université Paris-Saclay, UVSQ, APHP - Hôpital Ambroise ParéBoulogne-BillancourtFrance1